0      0

13 - Sponsored Product Theater: CDPATH™ a Personalized Prognostic Tool for Crohn’s disease

‐ Aug 14, 2021 6:00pm

Dr. Siegel discusses CDPATH, which uses a blood test to evaluate an adult patient’s potential risk within 3 years of developing bowel strictures, internal penetrating disease, or non-perianal surgery (bowel resection or stricturoplasty). Used with physician’s assessment, CDPATH can help facilitate shared decision-making (U.S. availability; no cost to eligible patients).

This Product Theater is sponsored by Takeda and is not affiliated with AGA.


You must be logged in and own this session in order to post comments.